Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Thermo Fisher Scientific Inc. company logo
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc. (TMO) EBITDA

Annual EBITDA

$10.89B$119.00M+1.10%

Summary

As of today, TMO annual EBITDA is $10.89B, up +1.10% on
TMO annual EBITDA is down -8.54% over the past 3 years, up +6.53% over the past 5 years
TMO annual EBITDA is currently -15.65% below its historical high of $12.91B set on
TMO annual EBITDA is +1.10% above its 3-year low of $10.77B reached on
TMO annual EBITDA is higher than 98.49% of companies in Healthcare sector

EBITDA Chart

SUGGESTED SERIES

Performance

TMO Performance
MetricDateValue1Y3Y5Y15Y
Annual EBITDA$10.89B+1.1%-8.5%+6.5%+443.3%
Quarterly EBITDA$3.29B+16.8%+16.3%+10.5%+446.3%
TTM EBITDA$12.26B+11.4%+12.9%-8.0%+444.0%
Price$709.18+27.0%+64.4%+12.0%+1279.7%
PE Ratio37.41+16.0%+32.3%+27.3%+92.7%
Annual Revenue$44.56B+3.9%-0.8%+38.3%+328.7%
Annual EPS$17.74+7.2%+0.5%+11.0%+603.0%
Annual EBIT$8.11B+5.8%-4.9%+2.7%+541.3%
Annual Net Income$6.72B+6.0%-3.5%+5.4%+581.6%

EBITDA Highs

TMO Annual EBITDA Highs Comparison
PeriodHighDateCurrent
3Y$11.91BN/A-8.5%
5Y$12.91B-15.7%
All$12.91B-15.7%

EBITDA Lows

TMO Annual EBITDA Lows Comparison
PeriodLowDateCurrent
3Y$10.77B+1.1%
5Y$10.22BN/A+6.5%
All$7.15M>+9999.0%

EBITDA History

YearValueChange
$10.89B+1.1%
$10.77B-0.8%
$10.85B-8.9%
$11.91B-7.8%
$12.91B+26.3%
$10.22B+56.4%
$6.54B+6.5%
$6.14B+15.8%
$5.30B+14.8%
$4.62B+10.4%
$4.18B+3.7%
$4.03B+44.1%
$2.80B+7.1%
$2.61B+11.6%
$2.34B+16.8%
$2.00B+5.2%
$1.91B-7.5%
$2.06B+13.0%
$1.82B+200.7%
$606.07M+45.3%
$417.05M+30.1%
$320.58M+9.8%
$292.10M+7.0%
YearValueChange
$273.10M-6.3%
$291.52M-7.4%
$314.93M-13.1%
$362.24M-33.7%
$546.60M+0.7%
$542.80M+35.9%
$399.27M+20.1%
$332.40M+37.3%
$242.10M+45.9%
$165.96M+70.2%
$97.49M+49.2%
$65.34M+20.3%
$54.34M+66.5%
$32.63M+4.4%
$31.25M+35.6%
$23.06M+10.8%
$20.81M+8.5%
$19.19M-0.3%
$19.25M+169.2%
$7.15M-41.1%
$12.15M-42.4%
$21.07M+27.4%
$16.54M-

FAQ

What is the current annual EBITDA of TMO?
As of today, TMO annual EBITDA is $10.89B
What is 1-year change in TMO annual EBITDA?
TMO annual EBITDA is up +1.10% year-over-year
What is 3-year change in TMO annual EBITDA?
TMO annual EBITDA is down -8.54% over the past 3 years
How far is TMO annual EBITDA from its all-time high?
TMO annual EBITDA is currently -15.65% below its historical high of $12.91B set on December 31, 2021
How does TMO annual EBITDA rank versus sector peers?
TMO annual EBITDA is higher than 98.49% of companies in Healthcare sector
When is TMO next annual earnings release?
The next annual earnings release for TMO is on

EBITDA Formula

EBITDA = Net Income + Interest Expense + Income Tax + D&A

Data Sources & References

  1. TMO Official Website www.thermofisher.com
  2. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/97745/000009774526000012/0000097745-26-000012-index.htm
  3. TMO Profile on Yahoo Finance finance.yahoo.com/quote/TMO
  4. TMO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tmo